These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9610669)

  • 21. Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment.
    Franchi S; Panerai AE; Sacerdote P
    Brain Behav Immun; 2007 Aug; 21(6):767-74. PubMed ID: 17291715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular mechanisms involved in morphine-mediated suppression of CTL activity.
    Carr DJ; Carpenter GW; Garza HH; Baker ML; Gebhardt BM
    Adv Exp Med Biol; 1995; 373():131-9. PubMed ID: 7668143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioids and opiates: analgesia with cardiovascular, haemodynamic and immune implications in critical illness.
    Molina PE
    J Intern Med; 2006 Feb; 259(2):138-54. PubMed ID: 16420543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signal transduction induced by opioids in immune cells: a review.
    Martin-Kleiner I; Balog T; Gabrilovac J
    Neuroimmunomodulation; 2006; 13(1):1-7. PubMed ID: 16612131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-inflammatory effects of opioids.
    Walker JS
    Adv Exp Med Biol; 2003; 521():148-60. PubMed ID: 12617572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissection of peripheral and central endogenous opioid modulation of systemic interleukin-1beta responses using c-fos expression in the rat brain.
    Buller KM; Hamlin AS; Osborne PB
    Neuropharmacology; 2005 Aug; 49(2):230-42. PubMed ID: 15993445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Murine Macrophage Cytokine Production After In Vivo Morphine Treatment.
    Franchi S; Castelli M; Moretti S; Panerai A; Sacerdote P
    Methods Mol Biol; 2021; 2201():199-207. PubMed ID: 32975801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The nervous system and the immune system: the role of morphine and opioid peptides in the function of neutrophilic granulocytes].
    Pasotti D; Mazzone A; Ricevuti G
    Minerva Med; 1992; 83(7-8):433-8. PubMed ID: 1326093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Opioids and immunosuppression. Clinical relevance?].
    Welters I
    Anaesthesist; 2003 May; 52(5):442-52. PubMed ID: 12750829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 'Immunomodulatory effects of opioids,' by Odunayo et al.
    McMillan M
    J Vet Emerg Crit Care (San Antonio); 2011 Feb; 21(1):3; author reply 3-4. PubMed ID: 21288287
    [No Abstract]   [Full Text] [Related]  

  • 31. Immune cell-mediated opioid analgesia.
    Machelska H; Celik MÖ
    Immunol Lett; 2020 Nov; 227():48-59. PubMed ID: 32814155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of interaction between morphine and interleukin-1 on the immune response.
    Chang SL; Wu GD; Patel NA; Vidal EL; Fiala M
    Adv Exp Med Biol; 1998; 437():67-72. PubMed ID: 9666258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity.
    Freier DO; Fuchs BA
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1127-33. PubMed ID: 7932161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
    Iyengar S; Kim HS; Wood PL
    Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of opioids on the immune system.
    Roy S; Loh HH
    Neurochem Res; 1996 Nov; 21(11):1375-86. PubMed ID: 8947928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endomorphins and activation of the hypothalamo-pituitary-adrenal axis.
    Coventry TL; Jessop DS; Finn DP; Crabb MD; Kinoshita H; Harbuz MS
    J Endocrinol; 2001 Apr; 169(1):185-93. PubMed ID: 11250660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biphalin preferentially recruits peripheral opioid receptors to facilitate analgesia in a mouse model of cancer pain - A comparison with morphine.
    Lesniak A; Bochynska-Czyz M; Sacharczuk M; Benhye S; Misicka A; Bujalska-Zadrozny M; Lipkowski AW
    Eur J Pharm Sci; 2016 Jun; 89():39-49. PubMed ID: 27094782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothesis on reciprocal interactions between the central and peripheral components of the endogenous opioid system.
    Sudakov SK; Trigub MM
    Bull Exp Biol Med; 2008 Dec; 146(6):663-6. PubMed ID: 19513349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transgenerational blunting of morphine-induced corticosterone secretion is associated with dysregulated gene expression in male offspring.
    Vassoler FM; Toorie AM; Byrnes EM
    Brain Res; 2018 Jan; 1679():19-25. PubMed ID: 29129606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.